Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. The Role of Glial Fibrillary Acidic Protein in the Neuropathology of Alzheimer's Disease and Its Potential as a Blood Biomarker for Early Diagnosis and Progression 2025-07-21
  2. Construction of a microcavity-based microfluidic chip with simultaneous SERS quantification of dual biomarkers for early diagnosis of Alzheimer's disease 2023-05-16
  3. The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease 2013-12-07

Studies

3 studies carry this tag.

Date range

2013 to 2025

Top journals

  • International journal of geriatric psychiatry 1
  • Molecular neurobiology 1
  • Talanta 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. The Role of Glial Fibrillary Acidic Protein in the Neuropathology of Alzheimer's Disease and Its Potential as a Blood Biomarker for Early Diagnosis and Progression

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. Molecular neurobiology 2025-07-21 Biomarkers

    Alzheimer's disease (AD) is a neurodegenerative disease characterised by neuropathological hallmarks, including extracellular amyloid plaques and neurofibrillary tangles.

  2. Since there is no effective Alzheimer's disease (AD)-modifying therapy available currently, early analysis of AD core biomarkers has become one of great significance and common concern in clinical diagnosis.

  3. The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. International journal of geriatric psychiatry 2013-12-07 Biomarkers

    The plasma Aβ40 biomarker was able to distinguish between AD and NC groups.

All topic tags with their study counts